Detalhe da pesquisa
1.
Portrait of blood-derived extracellular vesicles in patients with Parkinson's disease.
Neurobiol Dis
; 124: 163-175, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30408591
2.
Teneurin transmembrane protein 4 is not a cause for essential tremor in a Canadian population.
Mov Disord
; 32(2): 292-295, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28158909
3.
Electroencephalographic prodromal markers of dementia across conscious states in Parkinson's disease.
Brain
; 139(Pt 4): 1189-99, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26912643
4.
Genome-wide association study in essential tremor identifies three new loci.
Brain
; 139(Pt 12): 3163-3169, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27797806
5.
Deep Brain Stimulation Target Selection for Parkinson's Disease.
Can J Neurol Sci
; 44(1): 3-8, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26976064
6.
Establishing a Standard of Care for Deep Brain Stimulation Centers in Canada.
Can J Neurol Sci
; 44(2): 132-138, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27873569
7.
Prevalence of Convergence Insufficiency-Type Symptomatology in Parkinson's Disease.
Can J Neurol Sci
; 44(5): 562-566, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28862105
8.
Open-Label Study of Sleep Disturbances in Patients with Parkinson's Disease Treated with Rasagiline.
Can J Neurol Sci
; 43(6): 809-814, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27827298
9.
Eligibility Criteria for Deep Brain Stimulation in Parkinson's Disease, Tremor, and Dystonia.
Can J Neurol Sci
; 43(4): 462-71, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27139127
10.
Medical Management of Parkinson's Disease after Initiation of Deep Brain Stimulation.
Can J Neurol Sci
; 43(5): 626-34, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27670207
11.
Exome sequencing identifies FUS mutations as a cause of essential tremor.
Am J Hum Genet
; 91(2): 313-9, 2012 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-22863194
12.
Development and evaluation of a dyadic intervention for elderly couples living with moderate-stage Parkinson disease.
Appl Nurs Res
; 28(4): e21-7, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26324119
13.
Subthalamic stimulation improves motor function but not home and neighborhood mobility.
Mov Disord
; 29(14): 1816-9, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24849309
14.
Drug-induced dyskinesia in Parkinson's disease. Should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia?
BMC Med
; 11: 76, 2013 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-23514355
15.
Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson's disease: a prospective study.
Mov Disord
; 27(6): 720-6, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22322798
16.
A Man With Persistent Dopamine Agonist Withdrawal Syndrome After 7 Years Being Off Dopamine Agonists.
Can J Neurol Sci
; 43(6): 859-860, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26842385
17.
Combined 5-HT2A and mGlu2 modulation for the treatment of dyskinesia and psychosis in Parkinson's disease.
Neuropharmacology
; 186: 108465, 2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33485945
18.
Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease.
Ann Neurol
; 66(1): 39-47, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19670440
19.
Effect of Antidepressants on Psychotic Symptoms in Parkinson Disease: A Review of Case Reports and Case Series.
Clin Neuropharmacol
; 43(3): 61-65, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32217864
20.
Detecting the Cognitive Prodrome of Dementia in Parkinson's Disease.
J Parkinsons Dis
; 10(3): 1033-1046, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32310188